These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34073695)

  • 41. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent
    Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ;
    United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis.
    Dembrovszky F; Gede N; Szakács Z; Hegyi P; Kiss S; Farkas N; Molnár Z; Imrei M; Dohos D; Péterfi Z
    Infect Dis Ther; 2021 Mar; 10(1):201-211. PubMed ID: 33106983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.
    Kelly BJ; Tebas P
    Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection.
    Shaffer SR; Witt J; Targownik LE; Kao D; Lee C; Smieliauskas F; Rubin DT; Singh H; Bernstein CN
    J Infect; 2020 Nov; 81(5):758-765. PubMed ID: 32980389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Moving fecal microbiota transplantation into the mainstream.
    Orenstein R; Griesbach CL; DiBaise JK
    Nutr Clin Pract; 2013 Oct; 28(5):589-98. PubMed ID: 23979974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut Microbiota-Gut Metabolites and
    Gurung B; Stricklin M; Wang S
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38276309
    [No Abstract]   [Full Text] [Related]  

  • 48. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR; de Leon L; Jasutkar N
    J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.
    Abutaleb NS; Seleem MN
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253206
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
    Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
    PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consortium of Probiotics Attenuates Colonization of
    Li X; Chu Q; Huang Y; Xiao Y; Song L; Zhu S; Kang Y; Lu S; Xu J; Ren Z
    Front Microbiol; 2019; 10():2871. PubMed ID: 31921049
    [No Abstract]   [Full Text] [Related]  

  • 54. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.
    Patel NC; Griesbach CL; DiBaise JK; Orenstein R
    Mayo Clin Proc; 2013 Aug; 88(8):799-805. PubMed ID: 23910407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 57. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations.
    Brace C; Gloor GB; Ropeleski M; Allen-Vercoe E; Petrof EO
    J Crohns Colitis; 2014 Sep; 8(9):1133-7. PubMed ID: 24529606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Interactions between intestinal microbiota and Clostridioides difficile].
    Barbut F; Couturier J
    Rev Prat; 2019 Sep; 69(7):784-791. PubMed ID: 32233325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.